PharmaMénta Aps: Financial statements 2013
CVR: 25615697
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
PharmaMénta Aps (CVR 25615697) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK -6,555 and a net result of DKK 135,521 compared with DKK 286,184 the year before. Equity in the 2013 report amounted to DKK 4,133,830. The solvency ratio was 100%.
- Gross Profit
- DKK -6,555
- Profit/Loss
- DKK 135,521
- Equity
- DKK 4,133,830
- Total Assets
- DKK 4,135,830
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | -7 t. | 136 t. | 4.1 mio. | - |
| 2012 | - | -6 t. | 286 t. | 4 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
PharmaMénta Aps has published its annual report for 2012. Gross profit came to DKK -6,401, and the net result was DKK 286,184.
As of May 30, 2013, Partner Revision statsautoriseret revisionsaktieselskab has stepped down as auditor of PharmaMénta Aps.
About PharmaMénta Aps
PharmaMénta Aps is a Danish company of the type Anpartsselskab based in Esbjerg V, founded in 2000. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jimmi Javed Christensen Malik. The board consists of Lasse Hvingelby Kikkenborg (chair), Jimmi Javed Christensen Malik and Torben Hvingelby Pedersen. The company is owned by Torben Hvingelby Pedersen, LHK Holding Esbjerg ApS and JMINT Holding ApS. The company has 3 employees (2008). In 2025, the company reported a gross profit of DKK 5,249,012 and a net result of DKK 2,364,968 compared with DKK 2,121,363 the year before. Equity in the 2025 report amounted to DKK 5,130,022.